Business Standard

Cinemax India surges post Q2 results, stock doubles in 12 days

September 2012 quarter net profit at Rs 13.39 crore against Rs 7.98 crore in June 2012 quarter.

Related News

Cinemax India has locked in 10% upper circuit at Rs 151 after reporting a 68% quarter-on-quarter (qoq) growth in net profit at Rs 13.39 crore for the second quarter ended September 2012. The company engaged in theatre exhibition business had profit of Rs 7.98 crore in June 2012 quarter.

The company’s total income from operations grew 19% at Rs 100 crore in September from Rs 84 crore in the previous quarter, said in a statement.

Cinemax India is the resultant entity carrying the demerged theatre exhibition business of Cinemax Properties with effect from 1 April 2012.

Meanwhile, the stock has been more than doubled from Rs 74 after Reliance Media & Entertainment Fund had acquired 158,097 shares of the company for Rs 1.22 crore on October 29.

A combined 817,511 shares have already changed hands on the counter so far and there are pending buy orders for 178,043 shares on the BSE and NSE at 1510 hours.

Read more on:   
|
|

Read More

BSE launches carbon index

Premier bourse BSE, in collaboration with the UK government, today launched BSE Carbonex, the first-of-its-kind index in India or any emerging market ...

Quick Links

Market News

Markets rise on ECB tide

World markets rallied on Friday after the European Central Bank decided on Thursday to pump a little over about euro 1 trillion to revive the ...

ECB's QE unlikely to result in widespread gains for all asset classes

Cheap money to seek high-yielding assets; prices of others like industrial metals, gold could settle

Sensex records sharpest seven-day rally since 2009

The Sensex surged 273 points on Friday to close at 29,278.84, and has rallied 1,932 points in the past seven trading days since January 15

Gold imports came to halt as discounts widened

High discounts are due to huge carry over stock of gold imported in November

GSK Pharma, select MNC stocks gain as Sebi eases delisting norm

In intra-day trade, GSK Pharma gained as much as 12% and ended 6.4% higher at Rs 3,347.45

 

Back to Top